cStem Regeneration Pharmaceutical

cStem Regeneration Pharmaceutical is a biotechnology company focused on developing off-the-shelf regenerative therapies using induced pluripotent stem cell (iPSC) technology. Based in Suzhou, China, the company leverages its proprietary platform to differentiate iPSCs into high-purity functional cells, such as dopaminergic neurons and cardiomyocytes. Their lead programs target debilitating conditions including Parkinson's disease and heart failure, aiming to provide scalable and standardized cell therapy solutions. cStem's approach integrates advanced cell engineering with large-scale manufacturing capabilities to address significant unmet needs in degenerative medicine. The company is currently advancing its lead candidate through early-stage clinical trials in China.